Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Therapeutic Use of Botulinum Toxin Type A in Subacute Cervical/Upper Back Pain

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2006 by Palo Alto Institute for Research and Education, Inc.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Allergan
Information provided by:
Palo Alto Institute for Research and Education, Inc
ClinicalTrials.gov Identifier:
NCT00282958
First received: January 25, 2006
Last updated: NA
Last verified: January 2006
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2006
  Estimated Primary Completion Date: No date given